The Hagstrom Report

Agriculture News As It Happens

Navigation

‘Prescription farming’ plans depend on government information

The plans of John Deere, Monsanto and other companies to offer “prescription farming” services for individual farmers will be dependent on continued federal information gathering and statistical analysis, a series of experts said today at a congressional briefing entitled “Increasing U.S. Agriculture’s Competitive Edge: How Do Public Data and Big Data Fit?”

JB Penn

J.B. Penn
Much has been made of the ability of companies to collect an unprecedented amount of data on a farmer’s operations through modern technology, but the companies’ ability to make that individual farmer’s data meaningful “will depend on the statistics we have from the public sector,” said John Deere Chief Economist J.B. Penn, an Agriculture undersecretary for farm and foreign agricultural services in the George W. Bush administration.

“Every time a pass is made across the field you get new information that can be used in decision making,” Penn said, although he noted that individual needs to be combined with the kind of data collected by the government to develop the prescription.

Mary Bohman

Mary Bohman
Mary Bohman, the administrator of the Agriculture Department’s Economic Research Service, noted that ERS has a long history of collecting “quality, complex, credible information” and is “very efficient” in its data collection processes.

Mark Harris, the chair of the Agricultural Statistics Board of the USDA’s National Agricultural Statistics Service, noted that collecting the data across the nation’s 3,000 counties “is a little more challenging than some people realize.”

He also noted that NASS data cannot be subject to a Freedom of Information Act request and that farmers trust NASS and provide it with the data it needs for USDA’s many reports.

The event, sponsored by the nonprofit Council on Food, Agricultural and Resource Economics (C-FARE), seemed designed to convince congressional staff to keep up the budget for USDA statistical research.

But the panel also discussed some of the controversies surrounding big data.

Penn, the keynote speaker, said there are many issues about prescription farming and data collection that “need to be settled,” and American Farm Bureau Federation Chief Economist Bob Young said he believes the prescription farming business is so new and developing so fast that it may be different in 2015 compared to 2014.

Bob Young

Bob Young
Young said the big issue is “data ownership” and a farmer’s ability to get information back. Companies say “one thing” in their statement of principles and another in the contracts that they ask farmers to sign. Young said farmers wonder if information turned over to a private company could end up in the hands of a federal agency and be subject to a Freedom of Information Act request.

“USDA has a tremendous role to play as the referee,” Young said.

Farm Bureau has expressed concerns that companies or individuals may make use of a farmer’s data on field operations and expenses, but Ted Crosbie, a distinguished science fellow at Monsanto,The Climate Corporation, which Monsanto recently bought, has promised that farmers can reclaim their data.

The big issue for farmers is a fear that the data on such items as how much nitrogen was applied to a field and how much water was used will end up in the hands of federal regulators, Crosbie said.

Ted Crosbie

Ted Crosbie
“That is the hottest subject in any grower meeting you will have on this subject,” Crosbie said.

It is unclear, he added, whether the federal government could force a company to give the Environmental Protection Agency data on a farm with a “georeference” tag on it. Georeferencing — collecting data down to the square foot — is the only way to make prescription farming advice work, Crosbie noted.

The technical ability to collect the data is another challenge, he said, because so many areas of rural America have poor Internet and cell phone service.

The existence of the data on an individual farm raises issues between landlords and tenants, he noted. The tenant is likely to buy the prescription farming service, but Crosbie said he recently rewrote a lease so the landowner would also have access to the information because it would affect the value of the land.

Barry Goodwin

Barry Goodwin
Barry Goodwin, a North Carolina State University professor, noted that prescription farming raises so many legal, ethical and contractual issues that the industry will be racing to keep up with its development.

“There is value to the farmer, there is value to the technology companies,” Goodwin noted.

Questions also arose about whether the data collected by the companies would be valuable to the government.

Kitty Smith, a former ERS administrator, said that the government could benefit from a deeper knowledge of the soil management practices that the companies would develop.

Asked whether Monsanto, John Deere and other companies would compete on the basis of the content of their prescriptions or on price, Penn said he didn’t know and “if I knew I wouldn’t reveal it here today.”

Prescription farming, Penn said, “is uncharted territory. A lot of bets are being made. It is not going to be long before we know.”

Crosbie said Penn “covered it pretty well” and declined to comment further on Monsanto’s business strategy.

The Council on Food, Agricultural & Resource Economics — From Farm Income to Food Consumption: Valuing USDA Data ProductsThe Climate Corporation — Guiding Principles on Data and Privacy